FBP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
FBP is not a clear buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The technical trend is constructive, analysts are mostly positive, and the stock has supportive bank-sector fundamentals, but the current setup is already fairly extended, options activity is thin, and the recent lawsuit headline adds a negative overhang. Since the user is impatient and does not want to wait for a better entry, my direct view is to hold off on buying today and wait for a more attractive pullback or a cleaner catalyst.
The chart setup is bullish but not aggressive enough to justify a fresh long-term buy at the current level. SMA_5 is above SMA_20, and SMA_20 is above SMA_200, which confirms an uptrend. MACD histogram is positive at 0.0426, though it is contracting, suggesting upside momentum is still present but not accelerating. RSI_6 at 59.4 is neutral-to-bullish and not overbought. Price is sitting near pivot resistance around 26.05 with nearby resistance at 26.775 and 27.224, so near-term upside may be limited unless buyers push through resistance. Overall trend is positive, but entry quality is only متوسط, not ideal.
["Analysts remain constructive overall, with Raymond James setting a $32 target and maintaining Strong Buy.", "Raymond James cites ongoing loan growth momentum, benign credit trends, share repurchases, improved fee income, and expense control.", "BofA raised its target to $26 and kept a Buy rating, showing continued institutional confidence.", "Truist highlighted stable credit, expanding net interest margins, and modest balance sheet growth.", "Technical trend remains bullish with moving averages aligned upward.", "Hedge funds and insiders are both neutral rather than negative."]
["Recent lawsuit headline in New York related to banking services provided to Jeffrey Epstein creates reputational and legal overhang.", "Piper Sandler stayed Neutral and said valuation already reflects a justified premium to peers, implying limited upside.", "Option activity is very light, so options sentiment is not backed by strong trading volume.", "MACD momentum is positive but contracting, suggesting the move may be losing strength.", "The stock is already near resistance, reducing immediate entry attractiveness.", "No congress trading support and no influential insider/political buying signal."]
Latest quarter financials were not provided in usable detail, so a full quarter-by-quarter assessment is unavailable. From the analyst commentary tied to the recent Q1 and expected Q2 results, the operating picture appears favorable: loan growth momentum is continuing, credit trends remain benign, net interest margin expanded, expenses are controlled, fee income improved, and operating leverage is positive. That points to healthy underlying growth for the latest season referenced, but there are no actual reported financial line items in the data to confirm revenue, EPS, or margin percentages.
Analyst sentiment is mostly positive and has improved recently. Raymond James upgraded to Strong Buy and later lifted its target to $32 from $27, the highest target in the set. Truist, BofA, and Keefe Bruyette also raised targets, while Piper Sandler stayed Neutral and noted limited upside. The Wall Street pros view is constructive overall: better credit quality, NIM expansion, expense discipline, and buybacks. The main con is valuation, with at least one firm saying the shares already trade at a justified premium to peers and may have limited near-term upside.
